Home

Recommend Products

Special Offer

Bulk Products

New Arrivals

Hot Sales

Publication Products

Publication Products

Chemical Structure Cat. No. Product Name CAS No.
Pretomanid Chemical Structure
BCP21111 Pretomanid 187235-37-6
PA-824 is an experimental anti-tuberculosis drug and one of two nitroimidazoles in phase II clinical trials to treat tuberculosis.
Galunisertib Chemical Structure
BCP02173 Galunisertib 700874-72-2
LY2157299 is a novel selective small molecule transforming growth factor beta receptor (TGF-βR) kinase inhibitor with IC50 of 86 nM and 2 nM for TβR1 and 2 nM, respectively.
(Z)-Guggulsterone Chemical Structure
BCP07472 (Z)-Guggulsterone 39025-23-5
Z-guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, inhibits the growth of human prostate cancer cells by causing apoptosis. Z-guggulsterone inhibits angiogenesis by suppressing the VEGF–VEGF-R2–Akt signaling axis.
Ribavirin Chemical Structure
BCP03777 Ribavirin 36791-04-5
Ribavirin is a nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
Infliximab Chemical Structure
BCP20310 Infliximab 170277-31-3
Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
Belnacasan Chemical Structure
BCP02893 Belnacasan 273404-37-8
Belnacasan (VX-765) is an orally absorbed prodrug of VRT-043198, which exhibits potent inhibition against ICE/caspase-1 and caspase-4 with Ki of 0.8 nM and less than 0.6 nM, respectively.
BMS-202 Chemical Structure
BCP16068 BMS-202 1675203-84-5
BMS-202 is an inhibitor of the PD-1/PD-L1 protein/protein interaction, mainly used for cancer treatment.
Deshydroxyethoxy Ticagrelor Chemical Structure
BCP14589 Deshydroxyethoxy Ticagrelor 220347-05-7
Deshydroxyethoxy Ticagrelor analog of Ticagrelor an antiplatelet agent, and preventative in the treatment of heart attacks, myocardial infarction, and other pulmonary diseases.
Fexaramine Chemical Structure
BCP15784 Fexaramine 574013-66-4
Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity relative to natural compounds.
Ponatinib Chemical Structure
BCP02037 Ponatinib 943319-70-8
Ponatinib (AP24534) is a novel potent, orally available small molecule multitargeted kinase inhibitor with IC50 of 0.37, 2, 1.5, 2.2, 1.1, 1and 0.24 nM for native pan-BCR-ABL, mutated form, VEGFR2, FGFR1, PDGFRα, mutant FLT3 phosphorylation and LYN.
Luminespib Chemical Structure
BCP01827 Luminespib 747412-49-3
Luminespib is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90α and HSP90β, respectively.
Ostarine Chemical Structure
BCP02391 Ostarine 841205-47-8
Ostarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day.
CB-839 Chemical Structure
BCP28287 CB-839 1439399-58-2
CB-839 is a potent and orally bioavailable inhibitor of both splice variants of glutaminase (KGA and GAC), and with IC50s of 23 nM and 28 nM in kidney and brain, respectively.
Mirdametinib Chemical Structure
BCP01841 Mirdametinib 391210-10-9
Mirdametinib, also known as PD-0325901, is a potent bioavailable and selective MEK inhibitor, which targets mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity.
GDC-0941 Chemical Structure
BCP01714 GDC-0941 957054-30-7
Pictilisib, also known as Pictrelisib, GDC-0941, RG7321 and GNE0941 , is an orally bioavailable, and is a potent small-molecule thieno[3,2-d]pyrimidine inhibitor of the class I phosphatidylinositol 3 kinase (PI3K) isoforms p100alpha and p100delta with potential antineoplastic activity.
Orantinib Chemical Structure
BCP01984 Orantinib 252916-29-3
TSU-68 (SU6668)is a novel multiple receptor tyrosine kinase inhibitor with IC50 of 2.1 μM, 8 nM and 1.2 μM for VEGF-R1, PDGF-Rβ and FGF-R1, respectively.
Lapatinib Chemical Structure
BCP01874 Lapatinib 231277-92-2
Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.
Camptothecin Chemical Structure
BCP02857 Camptothecin 7689-03-4
Camptothecin is a potent DNA enzyme topoisomerase I inhibitor with an IC50 and IC70 of 50 nM and 0.225 μM for breast cancer cell line MDA-MB-231.
LY294002 Chemical Structure
BCP00195 LY294002 154447-36-6
LY294002 is a highly selective inhibitor of phosphatidylinositol 3-kinase.
Rapamycin Chemical Structure
BCP01404 Rapamycin 53123-88-9
Rapamycin is antifungal and immunosuppressant and specific inhibitor of mTOR.
123下一页末页共 105 条记录 1 / 6 页 
0086-13720134139